Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
Public ClinicalTrials.gov record NCT03983980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized double-blind vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.
Study identification
- NCT ID
- NCT03983980
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 515 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 6, 2019 (Actual)
- Primary completion
- May 13, 2020 (Actual)
- Completion
- May 29, 2020 (Actual)
- Last update posted
- Jun 12, 2025
2019 – 2020
United States locations
- U.S. sites
- 42
- U.S. states
- 25
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigative Site | Fort Smith | Arkansas | 72916 | — |
| Dermavant Investigative Site | Fountain Valley | California | 92708 | — |
| Dermavant Investigative Site | Fremont | California | 94538 | — |
| Dermavant Investigative Site | Los Angeles | California | 90045 | — |
| Dermavant Investigative Site | Oceanside | California | 92056 | — |
| Dermavant Investigative Site | San Diego | California | 92123 | — |
| Dermavant Investigative Site | Santa Monica | California | 90404 | — |
| Dermavant Investigative Site | Denver | Colorado | 80210 | — |
| Dermavant Investigative Site | Boynton Beach | Florida | 33437 | — |
| Dermavant Investigative Site | Margate | Florida | 33414 | — |
| Dermavant Investigative Site | Miami | Florida | 33144 | — |
| Dermavant Investigative Site | Boise | Idaho | 83713 | — |
| Dermavant Investigative Site | Rolling Meadows | Illinois | 60008 | — |
| Dermavant Investigative Site | Plainfield | Indiana | 46168 | — |
| Dermavant Investigative Site | Overland Park | Kansas | 66215 | — |
| Dermavant Investigative Site | Louisville | Kentucky | 40217 | — |
| Dermavant Investigative Site | Owensboro | Kentucky | 42301 | — |
| Dermavant Investigative Site | Metairie | Louisiana | 70006 | — |
| Dermavant Investigative Site | Boston | Massachusetts | 02215 | — |
| Dermavant Investigative Site | Bay City | Michigan | 48706 | — |
| Dermavant Investigative Site | Detroit | Michigan | 48202 | — |
| Dermavant Investigative Site | Fort Gratiot | Michigan | 48059 | — |
| Dermavant Investigative Site | Fridley | Minnesota | 55432 | — |
| Dermavant Investigative Site | Omaha | Nebraska | 68144 | — |
| Dermavant Investigative Site | Las Vegas | Nevada | 89148 | — |
| Dermavant Investigative Site | East Windsor | New Jersey | 08520 | — |
| Dermavant Investigative Site | Hackensack | New Jersey | 07601 | — |
| Dermavant Investigative Site | Stony Brook | New York | 11790 | — |
| Dermavant Investigative Site | Wilmington | North Carolina | 28405 | — |
| Dermavant Investigative Site | Winston-Salem | North Carolina | 27157 | — |
| Dermavant Investigative Site | Beachwood | Ohio | 44122 | — |
| Dermavant Investigative Site | Bexley | Ohio | 43209 | — |
| Dermavant Investigative Site | Portland | Oregon | 97223 | — |
| Dermavant Investigative Site | Charleston | South Carolina | 29414 | — |
| Dermavant Investigative Site | Nashville | Tennessee | 37215 | — |
| Dermavant Investigative Site | Houston | Texas | 77056 | — |
| Dermavant Investigative Site | Pflugerville | Texas | 78660 | — |
| Dermavant Investigative Site | Plano | Texas | 75024 | — |
| Dermavant Investigative Site | San Antonio | Texas | 78229 | — |
| Dermavant Investigative Site | Webster | Texas | 77598 | — |
| Dermavant Investigative Site | Norfolk | Virginia | 23502 | — |
| Dermavant Investigative Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03983980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03983980 live on ClinicalTrials.gov.